Figure 2. Temporal trends in overall oral anticoagulation prescription in total atrial fibrillation population (A) and patients with CHA₂DS₂-VASc score ≥2 (B).

NOAC = non-vitamin K antagonist oral anticoagulant; CHA₂DS₂-VASc = congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female).